Sven Hoffner

5.5k total citations
81 papers, 3.0k citations indexed

About

Sven Hoffner is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Sven Hoffner has authored 81 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Infectious Diseases, 71 papers in Epidemiology and 31 papers in Surgery. Recurrent topics in Sven Hoffner's work include Tuberculosis Research and Epidemiology (76 papers), Mycobacterium research and diagnosis (64 papers) and Infectious Diseases and Tuberculosis (22 papers). Sven Hoffner is often cited by papers focused on Tuberculosis Research and Epidemiology (76 papers), Mycobacterium research and diagnosis (64 papers) and Infectious Diseases and Tuberculosis (22 papers). Sven Hoffner collaborates with scholars based in Sweden, Germany and China. Sven Hoffner's co-authors include Pontus Juréen, Jim Werngren, Kristian Ängeby, Dan I. Andersson, Yohannes Mengistu, Gunilla Källenius, Freddie Bwanga, Melles Haile, Moses Joloba and Solomon Ghebremichael and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sven Hoffner

81 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sven Hoffner Sweden 32 2.7k 2.4k 1.0k 556 356 81 3.0k
Vishwa Mohan Katoch India 31 2.1k 0.8× 1.7k 0.7× 737 0.7× 676 1.2× 245 0.7× 94 2.8k
C N Paramasivan India 32 2.5k 0.9× 2.1k 0.9× 1.1k 1.1× 507 0.9× 160 0.4× 96 3.2k
A László Canada 21 2.5k 0.9× 2.2k 0.9× 1.0k 1.0× 367 0.7× 159 0.4× 46 2.9k
Natalia Kurepina United States 25 2.4k 0.9× 2.2k 0.9× 1.2k 1.2× 700 1.3× 235 0.7× 55 2.9k
Thomas C. Victor South Africa 34 2.9k 1.1× 2.5k 1.0× 1.3k 1.2× 713 1.3× 341 1.0× 59 3.4k
Nicolas Véziris France 32 2.7k 1.0× 2.7k 1.1× 760 0.7× 784 1.4× 441 1.2× 139 3.5k
B.W. Allen United Kingdom 21 1.7k 0.7× 1.6k 0.7× 695 0.7× 535 1.0× 251 0.7× 40 2.4k
Moisés Palaci Brazil 30 2.1k 0.8× 1.9k 0.8× 682 0.7× 318 0.6× 136 0.4× 96 2.6k
Ákos Somoskövi United States 24 1.9k 0.7× 1.9k 0.8× 763 0.7× 301 0.5× 125 0.4× 68 2.5k
Deepak V. Almeida United States 27 1.7k 0.6× 1.5k 0.6× 445 0.4× 591 1.1× 252 0.7× 51 2.1k

Countries citing papers authored by Sven Hoffner

Since Specialization
Citations

This map shows the geographic impact of Sven Hoffner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Hoffner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Hoffner more than expected).

Fields of papers citing papers by Sven Hoffner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Hoffner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Hoffner. The network helps show where Sven Hoffner may publish in the future.

Co-authorship network of co-authors of Sven Hoffner

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Hoffner. A scholar is included among the top collaborators of Sven Hoffner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Hoffner. Sven Hoffner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farnia, Poopak, Jalaledin Ghanavi, Majid Marjani, et al.. (2022). Effect of COVID-19 Pandemic on Incidence of Mycobacterial Diseases among Suspected Tuberculosis Pulmonary Patients in Tehran, Iran. International Journal of Mycobacteriology. 11(4). 415–422. 10 indexed citations
2.
Hu, Yi, Xubin Zheng, Lina Davies Forsman, et al.. (2021). Emergence of additional drug resistance during treatment of multidrug-resistant tuberculosis in China: a prospective cohort study. Clinical Microbiology and Infection. 27(12). 1805–1813. 5 indexed citations
3.
Shi, Wenpei, Lina Davies Forsman, Yi Hu, et al.. (2020). Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China. International Journal of Infectious Diseases. 96. 390–397. 9 indexed citations
4.
Zheng, Xubin, Lina Davies Forsman, Yi Hu, et al.. (2020). Drug Exposure and Minimum Inhibitory Concentration Predict Pulmonary Tuberculosis Treatment Response. Clinical Infectious Diseases. 73(9). e3520–e3528. 34 indexed citations
5.
6.
Hoffner, Sven, et al.. (2019). Direct drug susceptibility testing of Mycobacterium tuberculosis using the proportional method: A multicenter study. Journal of Global Antimicrobial Resistance. 17. 242–244. 15 indexed citations
7.
Zhang, Zhengdong, Jianping Deng, Mikael Mansjö, et al.. (2018). Multi-center evaluation of GenoType MTBDRsl line probe assay for rapid detection of pre-XDR and XDR Mycobacterium tuberculosis in China. Journal of Infection. 77(4). 328–334. 14 indexed citations
8.
Velayati, Ali Akbar, Parissa Farnia, & Sven Hoffner. (2017). Drug-resistant Mycobacterium tuberculosis: Epidemiology and role of morphological alterations. Journal of Global Antimicrobial Resistance. 12. 192–196. 28 indexed citations
9.
Drobniewski, Francis, et al.. (2014). Evaluation of a biphasic media assay for pyrazinamide drug susceptibility testing of Mycobacterium tuberculosis. Journal of Antimicrobial Chemotherapy. 69(11). 3001–3005. 5 indexed citations
10.
Cambau, Emmanuelle, Miguel Viveiros, Diana Machado, et al.. (2014). Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study. Journal of Antimicrobial Chemotherapy. 70(3). 686–696. 71 indexed citations
11.
Walusimbi, Simon, Freddie Bwanga, Ayesha De Costa, et al.. (2013). Evaluation of the Xpert® MTB/Rif test, microscopic observation drug susceptibility test and nitrate reductase assay, for rapid and accurate diagnosis of smear-negative tuberculosis in HIV patients. SHILAP Revista de lepidopterología. 2(3). 148–155. 5 indexed citations
12.
Ahmed, Raija, Kithiganahalli Narayanaswamy Balaji, Sven Hoffner, et al.. (2012). Pattern recognition and cellular immune responses to novel Mycobacterium tuberculosis-antigens in individuals from Belarus. BMC Infectious Diseases. 12(1). 41–41. 12 indexed citations
13.
Hu, Yi, et al.. (2010). Genetic characterisation of drug-resistant Mycobacterium tuberculosis in rural China: a population-based study.. PubMed. 14(2). 210–6. 9 indexed citations
14.
15.
Wright, A, Matteo Zignol, Armand Van Deun, et al.. (2009). Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. The Lancet. 373(9678). 1861–1873. 291 indexed citations
16.
Ghebremichael, Solomon, Tuija Koivula, Alexandra Pennhag, et al.. (2008). Molecular epidemiology of drug-resistant tuberculosis in Sweden. Microbes and Infection. 10(6). 699–705. 23 indexed citations
17.
Marklund, Britt‐Inger, et al.. (2005). Mycobacterium avium with the bird type IS1245 RFLP profile is commonly found in wild and domestic animals, but rarely in humans. Scandinavian Journal of Infectious Diseases. 37(1). 15–20. 29 indexed citations
18.
Weezenbeek, C.S.B. Lambregts-van, Maria Luisa Moro, F. Drobniewski, et al.. (2000). Standardization of antituberculosis drug resistance surveillance in EuropeRecommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. European Respiratory Journal. 16(2). 364–364. 71 indexed citations
19.
Abate, Getahun & Sven Hoffner. (1997). Synergistic antimycobacterial activity between ethambutol and the beta-lactam drug cefepime. Diagnostic Microbiology and Infectious Disease. 28(3). 119–122. 13 indexed citations
20.
Hoffner, Sven, et al.. (1990). Susceptibility of Mycobacteria to fusidic acid. European Journal of Clinical Microbiology & Infectious Diseases. 9(4). 294–297. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vishwa Mohan Katoch Breakdown of academic impact, for papers by C N Paramasivan Breakdown of academic impact, for papers by A László Breakdown of academic impact, for papers by Natalia Kurepina Breakdown of academic impact, for papers by Thomas C. Victor Breakdown of academic impact, for papers by Nicolas Véziris Breakdown of academic impact, for papers by B.W. Allen Breakdown of academic impact, for papers by Moisés Palaci Breakdown of academic impact, for papers by Ákos Somoskövi Breakdown of academic impact, for papers by Deepak V. Almeida
Rankless by CCL
2026